Links from this page to related variants, conditions, drugs and topics are not included for automated readers. Those connections are the Gene Knowledge Graph and are licensed as data: https://www.mygenelog.com/license

Sensitive

Moderate or severe diarrhoea in darapladib-treated cardiovascular disease (time to event)

AC006465.3 · rs145044782

Strength of the evidence

1 / 4

Its strongest genetic-study result is p = 10−8, with 1 associations in the GWAS Catalog.

How this is scored

4: ClinVar disease-causing, reviewed by an expert panel or a guideline (3–4 stars). 3: ClinVar, several labs agreeing (2 stars), or a genetic study at p ≤ 10−50. 2: ClinVar from one lab (1 star), or p ≤ 10−20. 1: ClinVar submitted without criteria (0 stars), or genome-wide significance (p ≤ 5×10−8). The higher of the two counts. It says how solid the evidence is, not whether it matters for a particular person.

What the study found

Who was studied 212 European ancestry cases.

The effect Each copy of the A allele carried 10.88 times the odds of Moderate or severe diarrhoea in darapladib-treated cardiovascular disease (time to event) (95% confidence interval 4.67-25.38); p = 3 × 10−8.

How common The A allele had a frequency of about 1% in the people studied.

Where it sits Chromosome 7, band 7p21.3 — in an intron of GLCCI1.

How common each version is

AG
Korean KRGDB
A 0.0% · G 100.0%
Japanese ToMMo
A 0.0% · G 100.0%
World gnomAD
A 2.8% · G 97.2%
World 1000 Genomes
A 3.2% · G 96.8%
World TOPMed
A 3.2% · G 96.8%

By ancestry gnomAD

European (non-Finnish)
G 99.8%
African / African American
A 9.0% · G 91.0%
South Asian
G 99.9%
Admixed American (Latino)
A 2.0% · G 98.0%
Middle Eastern
A 3.8% · G 96.2%
Ashkenazi Jewish
A 0.7% · G 99.3%

The share of all copies of this position that are each version. Source: the population studies published in dbSNP (US NCBI); each row names its study. The ancestry rows are gnomAD's own groups (via Ensembl), as the survey defines them, not races.

What each result means

A/A Two copies of the version the research linked to Moderate or severe diarrhoea in darapladib-treated cardiovascular disease (time to event). That is the strongest link of the three results. A link in a study is not a diagnosis.
A/G One copy of the version the research linked to Moderate or severe diarrhoea in darapladib-treated cardiovascular disease (time to event). That is a smaller link than two copies.
G/G No copy of the version the research linked to Moderate or severe diarrhoea in darapladib-treated cardiovascular disease (time to event). This is the starting point the study compared everyone against.
Source

Quoting this page

Licensed CC BY-NC 4.0: free to read, share and adapt for non-commercial use, naming MyGeneLog™ and linking the exact page. Commercial use, including training or serving a commercial AI system, needs a licence — https://www.mygenelog.com/license

Moderate or severe diarrhoea in darapladib-treated cardiovascular disease (time to event) (rs145044782). MyGeneLog™. https://www.mygenelog.com/variants/rs145044782

← See all variants